Tovetumab (MEDI-575) is a fully human monoclonal antibody that exhibits high selectivity for platelet-derived growth factor receptor alpha (PDGFRalpha). it functions by specifically inhibiting PDGFRalpha signal transduction pathways, and it is currently being utilized in clinical research for the treatment of aggressive malignancies including glioblastoma and non-small cell lung cancer (NSCLC).
Purity:
95.40%
CAS Number:
[1243266-04-7]
Target:
PDGFR
* VAT and and shipping costs not included. Errors and price changes excepted
